WuXi XDC Cayman Inc.
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associa… Read more
WuXi XDC Cayman Inc. (L74) - Total Liabilities
Latest total liabilities as of June 2025: €3.18 Billion EUR
Based on the latest financial reports, WuXi XDC Cayman Inc. (L74) has total liabilities worth €3.18 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
WuXi XDC Cayman Inc. - Total Liabilities Trend (2021–2024)
This chart illustrates how WuXi XDC Cayman Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
WuXi XDC Cayman Inc. Competitors by Total Liabilities
The table below lists competitors of WuXi XDC Cayman Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oberbank AG
VI:OBS
|
Austria | €24.67 Billion |
|
OliX PharmaceuticalsInc
KQ:226950
|
Korea | ₩44.02 Billion |
|
Indra Sistemas S.A
OTCGREY:ISMAF
|
USA | $5.03 Billion |
|
Sumitomo Rubber Industries Ltd
F:108
|
Germany | €693.72 Billion |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
USA | $14.10 Billion |
|
Wuchan Zhongda Group Co Ltd
SHG:600704
|
China | CN¥164.05 Billion |
|
Zabka Group S.A.
WAR:ZAB
|
Poland | zł17.19 Billion |
|
Camurus AB (publ)
OTCGREY:CAMRF
|
USA | $553.52 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down WuXi XDC Cayman Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WuXi XDC Cayman Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WuXi XDC Cayman Inc. (2021–2024)
The table below shows the annual total liabilities of WuXi XDC Cayman Inc. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.48 Billion | +93.96% |
| 2023-12-31 | €1.28 Billion | +26.13% |
| 2022-12-31 | €1.02 Billion | +18.25% |
| 2021-12-31 | €858.87 Million | -- |